Skip to main content

Mass General Brigham

By Nathan Eddy | 11:25 am | March 12, 2026
At HIMSS26, leaders from Emory Healthcare and Mass General Brigham discussed how initiatives like the Healthcare AI Challenge aim to help health systems make safer deployment decisions.
Emerging Technologies
By Jessica Hagen | 11:29 am | February 17, 2026
Esther Kim, head of emerging technologies and solutions at Mass General Brigham, speaks with MobiHealthNews about evaluating new technologies through an operational lens and balancing innovation with real-world feasibility.
By Anthony Vecchione | 07:24 pm | March 06, 2025
The panelists highlighted digital health investments, innovation, interoperability and integration.  
By Anthony Vecchione | 03:51 pm | December 20, 2024
A study published in the Journal of Medical Artificial Intelligence found that large language models can offer helpful physical exam recommendations and instructions based on symptoms. 
By Nathan Eddy | 01:01 pm | March 06, 2024
The healthcare system will translate its advanced algorithms pertaining to rapid response clinical scenarios into AvoMD's application.
By Jessica Hagen | 01:47 pm | November 08, 2023
The retail giant and the Massachusetts-based healthcare system will develop custom tools to support the provider's Healthcare at Home offerings and devise new tech.
By HIMSS TV | 07:00 am | October 10, 2023
Dr. Adam Landman, chief information officer at Mass General Brigham, relays how generative AI and LLM technology are changing the healthcare workforce burden and how these scalable solutions improve efficiencies within the health system.
By Jessica Hagen | 01:52 pm | September 07, 2023
THE IQ-Creator Program supports healthcare professionals in creating content for underserved communities, while Aloud uses AI to dub videos in multiple languages.
By Jessica Hagen | 01:57 pm | September 06, 2023
The algorithm helps predict missed appointments, failure to schedule follow-up visits and late arrivals.
By Laura Lovett | 02:55 pm | November 02, 2021
The study will focus on Type 2 diabetes patients.